Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FG-4592 and Warfarin Interaction Study
NCT02252731Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2013
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of roxadustat in anemia of chronic kidney disease (CKD-A), sponsored by Astellas Pharma. Primary endpoints: Area under the curve from the time of dosing extrapolated to time infinity for S-warfarin and R-warfarin and Maximum concentration for S-warfarin and R-warfarin. Started Sep 2013; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02252731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02252731.